Tarsus Pharmaceuticals, Inc. TARS Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s other intangible assets—net?
- Tarsus Pharmaceuticals, Inc. (TARS) reported other intangible assets—net of $7.13M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s other intangible assets—net changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s other intangible assets—net decreased by 11.9% year-over-year, from $8.09M to $7.13M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.